BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


SMALL-CAP WINNERS & LOSERS: UP Global Sourcing rises on upbeat outlook


BATM Advanced Communications ups guidance on rampant profit growth


UK earnings, trading statements calendar - next 7 days


TRADING UPDATES: Westmount comes up empty; Blencowe ahead of schedule


TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland


TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls


SMALL-CAP WINNERS & LOSERS: Treatt rises after positive outlook


BATM Advanced enters agreement with albis-elcon for network technology